For the first time, Chinese pharmaceutical companies are among the top 25 pharmaceutical brands in the world.
Sinopharm and Shanghai pharmaceutical (SPH) have become the only two Chinese brands to be included in the Brand Finance Pharma 25 2020 ranking！Including takeda, three pharmaceutical companies in Asia have entered the global ranking!
This year, the pharmaceutical industry's most valuable brands expanded to 25 for the first time, and Asian brands appeared in the rankings for the first time, with sinopharm ranked 15th with a brand value of about $2bn. Johnson & Johnson, roche, bayer, Pfizer and other foreign pharmaceutical companies continue to top the list, but for a variety of reasons, most of the brand value has declined to varying degrees.
Brand Finance (Hong Kong) Ltd director Anthony Pettifer said:“As Chinese companies extend their brands into new markets there is little doubt we are approaching the point when names like Sinopharm (#54) may become as well known internationally as Pfizer or Roche”.